Sai Lv1, Wei Liu1, Yujie Zhou2, Yuyang Liu1, Dongmei Shi1, Yingxin Zhao1, Xiaoli Liu1, Jumana W Alhelal3, K S Shakeenah Ravuru3. 1. Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China. 2. Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China. azzyj12@163.com. 3. International School of Capital Medical University, Beijing, China.
Abstract
BACKGROUND: Coronary artery disease (CAD) in adults ≤ 35 years of age is rare, but the incidence is on the rise and the risk factors for this age group are largely uncertain. Previous studies have shown that hyperuricemia (HUA) is an independent risk factor for CAD in the general population, whereas the role in adults ≤ 35 years of age with acute coronary syndrome (ACS) is unclear. METHODS: Patients, 18-35 years of age, diagnosed with ACS for the first time at the documented institu- tion between January 2005 and December 2015, were enrolled in the current study. The severity of CAD was assessed by the Gensini score. Patients were divided into two groups according to the definition of HUA. The relationship between HUA and CAD severity was assessed based on multi-variate analysis. RESULTS: Seven hundred seventy-one participants fulfilling the criteria were included in this study (mean age, 31.6 years; 94.4% male). HUA, which was defined as a serum uric acid level ≥ 7.0 mg/dL (420μmol/L) in males and ≥ 6.0 mg/dL (357 μmol/L) in females, accounted for 37% of the participants. Multivariate analysis identified that HUA is an independent risk factor of CAD severity, as assessed by the Gensini score, in very young adults with ACS (OR 8.28; 95% CI 1.96-14.59; p = 0.01), and the effect of HUA on CAD severity was second only to diabetes mellitus. CONCLUSIONS: Hyperuricemia was shown to be an independent risk factor for CAD severity in young adults with ACS (18-35 years of age).
BACKGROUND:Coronary artery disease (CAD) in adults ≤ 35 years of age is rare, but the incidence is on the rise and the risk factors for this age group are largely uncertain. Previous studies have shown that hyperuricemia (HUA) is an independent risk factor for CAD in the general population, whereas the role in adults ≤ 35 years of age with acute coronary syndrome (ACS) is unclear. METHODS:Patients, 18-35 years of age, diagnosed with ACS for the first time at the documented institu- tion between January 2005 and December 2015, were enrolled in the current study. The severity of CAD was assessed by the Gensini score. Patients were divided into two groups according to the definition of HUA. The relationship between HUA and CAD severity was assessed based on multi-variate analysis. RESULTS: Seven hundred seventy-one participants fulfilling the criteria were included in this study (mean age, 31.6 years; 94.4% male). HUA, which was defined as a serum uric acid level ≥ 7.0 mg/dL (420μmol/L) in males and ≥ 6.0 mg/dL (357 μmol/L) in females, accounted for 37% of the participants. Multivariate analysis identified that HUA is an independent risk factor of CAD severity, as assessed by the Gensini score, in very young adults with ACS (OR 8.28; 95% CI 1.96-14.59; p = 0.01), and the effect of HUA on CAD severity was second only to diabetes mellitus. CONCLUSIONS:Hyperuricemia was shown to be an independent risk factor for CAD severity in young adults with ACS (18-35 years of age).
Entities:
Keywords:
Gensini score; coronary artery disease; hyperuricemia; severity; young adults
Authors: Claudio Borghi; Andrzej Tykarski; Krystyna Widecka; Krzysztof J Filipiak; Justyna Domienik-Karłowicz; Katarzyna Kostka-Jeziorny; Albert Varga; Milosz Jaguszewski; Krzysztof Narkiewicz; Giuseppe Mancia Journal: Cardiol J Date: 2018 Impact factor: 2.737
Authors: Gregory G Schwartz; Anders G Olsson; Markus Abt; Christie M Ballantyne; Philip J Barter; Jochen Brumm; Bernard R Chaitman; Ingar M Holme; David Kallend; Lawrence A Leiter; Eran Leitersdorf; John J V McMurray; Hardi Mundl; Stephen J Nicholls; Prediman K Shah; Jean-Claude Tardif; R Scott Wright Journal: N Engl J Med Date: 2012-11-05 Impact factor: 91.245
Authors: Małgorzata Buksińska-Lisik; Przemysław Kwasiborski; Robert Ryczek; Wojciech Lisik; Artur Mamcarz Journal: J Clin Med Date: 2022-04-26 Impact factor: 4.964